Building Something That Lasts: The Unusual Journey of Dr. D. Fernando Estrada, Who Put His Inner Gremlin on a Shelf
By Janie McGlohon & Simone Brixius-Anderko, Communications Officers, DMD Division
The Okita Early Career Achievement Award, established by the ASPET Division for Drug Metabolism and Disposition, honors investigators whose originality, independence, and impact have left a distinct mark on the field. This year’s recipient, Dr. D. Fernando Estrada, embodies that spirit. His journey into science was anything but traditional—shaped by years of military service, the challenges of being a first-generation student, and an unwavering drive to “build something that lasts.” What began as an interest in community college evolved into a career defined by innovation, mentorship, and discovery, making Dr. Estrada a fitting honoree for an award that recognizes excellence and originality in drug metabolism and disposition research.
For Dr. Estrada, science was never a childhood certainty—it was a path discovered later in life, shaped by curiosity. “I was a late bloomer when it came to science,” Estrada recalls. “I always found it interesting, but I didn’t really see it as a career option until much later. Scientists just weren’t in my orbit, so it wasn’t something I imagined for myself.” The catalyst came in community college, where small class sizes and an approachable professor made science accessible and engaging. Organic chemistry captured his interest, but it was the last chapter in the textbook, biochemistry, that ultimately fueled his curiosity. “Even though we weren’t required to read it, I found it fascinating,” he explains. “I really liked the idea that everything was connected—how the rules that govern a protein can tell you something about proteins in humans versus bacteria.”
Looking back, Dr. Estrada acknowledges there were more direct routes to science, but his path was shaped by circumstances. “I’m one of six kids, and while my family was supportive, resources were limited. They didn’t have the ‘map’ to navigate college, and neither did I. That’s common with first-gen students. You see a little piece of the map, but not the whole thing.” Dr. Estrada took a detour from science, serving in the military after college, which helped fund his education. What may have seemed like a diversion ultimately became a foundation—teaching skills and discipline that translated seamlessly into research. His army experience helped shape his science and leadership style. “The mindset and critical thinking translate well with planning, testing hypotheses, preparing for multiple outcomes. The transition between the military and academia wasn’t jarring. Both involve training young people who are away from home for the first time, building support systems. In many ways, it felt familiar.”
When Dr. Estrada finally returned to science, he approached it with the same decisiveness that had guided his military service. “I only applied to one PhD program. I didn’t know you were supposed to apply to multiple. That first-gen mindset was still with me—I was lucky to get in.” Graduate school came with risks. He left behind a stable salary as an Army officer to take on the financial uncertainty of a graduate stipend—all while starting a family. “Starting grad school was scary. I was taking a personal financial risk. But I was happier in the lab doing research. Once I got into it, I realized how fulfilling it is.”
Estrada’s path into structural biology was equally serendipitous. Initially passionate about biochemistry, he was drawn to Nuclear Magnetic Resonance (NMR) during his rotations. “I did rotations that were very biochemistry-focused, but the last lab I rotated in is the one I joined. I’d originally started in a fly lab because that PI was also ex-Army, but I didn’t want to pursue that. I liked NMR because it felt familiar. It reminded me of topography maps: peaks, valleys, contours. As someone who worked in military intelligence, I used to advise commanders on possible enemy actions and resource planning. That kind of hypothesis generation and testing translated well to science.” That decision positioned him uniquely in the cytochrome P450 community. “During my PhD, I worked on scaffolding proteins—not enzymes. But when I joined Dr. Emily Scott’s lab, I entered the cytochrome P450 (P450) field. Their relevance to human health intrigued me.”
Following his postdoc, Dr. Estrada reached a pivotal decision point shared by many graduate students—choosing between a faculty role and a career in industry. “My transition into a faculty role wasn’t immediate. It took time to realize this was even possible. Dr. Scott encouraged independence and grant writing. The fundraising aspect, which scares most people, started to feel achievable. I wouldn’t be where I am without her mentorship. It was serendipity that Dr. Scott came into my life.”
Estrada is candid about the challenge of work-life-balance in science. “The biggest challenge was balancing family life. I’ve had a supportive family and, frankly, the privilege of being male. Expectations are different for women, and I saw that with my female peers in grad school. There wasn’t much parental leave then. I know I’ve had privilege in that regard.” For him, family is both grounding and motivating. “Everyone has to find what works for them. For me, it’s my kids. They take up most of my free time—school, sports like football and ice skating.”
Like many scientists, Dr. Estrada has wrestled with imposter syndrome, or what he calls the gremlin. “The idea that you can get rid of imposter syndrome is not always true. I once read an interview with Michelle Obama where she talked about her imposter syndrome, and I thought, If she can’t get rid of it, I’m not getting rid of mine. So, I don’t feed it.” Like in the movie, feeding a gremlin after midnight causes chaos. Similarly, giving energy to imposter syndrome only makes it more destructive. So Estrada puts his gremlin on the shelf. He acknowledges it’s there, but he “tries not to compare myself to others—that’s how it grows. Instead, I compare myself to who I was five years ago. That’s a better measure.” Over time, Estrada’s measure of success has also evolved. “Early on, success meant grants, papers, funding. But eventually, that stops being enough. Now, my measure of success is my students—where they go and what they do. I think, I’ve prepared this person for the world, and that’s a source of pride. If my mentees don’t succeed, I take that personally. That wasn’t how I saw it at the start, but that’s how I see it now.”
The path to success looks different for everyone, and it’s rarely achieved through a single effort. Many face additional challenges, either coming from nontraditional or underrepresented backgrounds, or without educational support. Dr. Estrada emphasizes that there’s no single path to science. “Find your people—the ones who will support you. If no one around you is supporting you, seek out those who will. Maybe it’s a former teacher, a TA, or a professor. Start building that network.” For undergraduates, he offers practical advice: “It’s important for undergrads to get into a lab and observe what grad school is really like. That takes away the mystery and shows you the steps. And you don’t have to take on more student debt to go to grad school. I didn’t know that when I was applying. Put yourself in the right environments, and don’t be afraid to ask for help.”
From the Army to academia, from uncertainty to leadership, Dr. Estrada’s journey embodies resilience, originality, and a commitment to building something lasting. His Okita Award not only recognizes his scientific achievements, but also the impact he continues to have as a mentor and role model in the field of drug metabolism and disposition.
This award is very personal. Dr. Okita has been a constant presence in my development as a scientist. With his recent retirement, it’s become clear that his work at the NIH has had a lasting impact on not only myself but many other ASPET members. Awards like these are also an opportunity to shine a light on the hard and often thankless work that is being performed by countless dedicated civil servants like Dr. Okita. Academic research would not be possible without their tireless efforts.
Dr. Estrada
Fernando exemplifies the spirit of Dick Okita in terms of giving back. He has given back at multiple levels. Before even coming into the P450 field, he gave back by serving his country in the Iraq War. In my laboratory, he gave back in terms of providing a serious, top-notch example of how to do science—even when the going was hard and success uncertain—and to do it in a personable, team-based way.
Dr. Emily Scott
University of Michigan, Postdoc mentor
It is an incredible challenge to express my gratitude for Fernando—my #1 supporter and cheerleader throughout graduate school, both professionally and personally.
Layne Jensen
Graduate student in the Estrada lab
His humility and appreciation for the work we were putting in made his mentorship especially meaningful. Every Monday, we had a full hour to go over the previous week’s data, brainstorm new ideas, and just talk science. Fernando’s enthusiasm in these meetings was contagious.
Dr. Chris Campomizzi
Former graduate student in the Estrada lab
ASPET Welcomes New Members
Each month, ASPET welcomes new members to our home for pharmacology. This month, we recognize 84 individuals from 49 universities, colleges, and companies who have joined 4,000 other members in the pharmacology community. Learn more about ASPET membership.
Arab Academy for Science, Technology & Maritime Transport
Mohamed Noureldin
Boston University School of Medicine
Travis Rotterman
Vladimir Tkachev
Campbell University
Sarena Gresko
Damanhour University
Hisham Nematalla
Egyptian Drug Authority
Eba Mansour
Ekiti State University
Yemisi Alli Smith
Emory University
Emily Mathus
Indiana University Health Methodist Hospital
Nastassja Sardinas
Instituto Tecnológico y de Estudios Superiores de Monterrey
Diego Pacheco
Jawaharlal Nehru Medical College, AMU
Ammar Khalid
Johnson & Johnson
Sam Wouters
Lady Hardinge Medical College
Abhiram Suresh Babu
Massachusetts College of Pharmacy and Health Sciences
Sebastian Uribe Leon
Mayo Clinic
Isaac Prah
Mayo Clinic Graduate School of Biomedical Science
Joseph Carey
Mclean Hospital
Kwang-Hyun Hur
Medical College of Wisconsin
Brian Lin
National Institute on Drug Abuse
Nicholas Gonzalez
North Dakota State University
Khaled Mohamed
Ohio Northern University
Katelyn Messner
Ohio State University
Alexander Ham
Jin Gyu Kim
Aliza Klein
Kartik Nimkar
Purdue University Lib TSS
Sandali Piladuwa Gamage
Rutgers University
Raymond Chien
Kimia Didehvar
Vipin Rao
Rutgers New Jersey Medical School
Jin Xu
State University New York at Buffalo
Ruth-Ann Saddler
Stony Brook University
Holly Colognatao
Texas Tech University Health Science Center
Bisola Ojo
University of Connecticut
Michael Lehane
Afshin Seyednejad
University of North Texas Health Science Center
Hannah Ampofo
University of Central Florida College of Medicine
Heidi Smith Hoopingarner
University of Colorado
Beatrice Finch
University of Colorado Anschutz Medical Campus
Phaedra Whitty
University of Illinois at Chicago
Samantha Niecestro Jackson
University of Iowa
Nathan Fassett
Danlin Liu
Brenna Powers
University of Maryland Baltimore
Mahder Abate
University of Michigan
Carley Beeman
Brandon Buscher
Avery Campbell
Samuel Collie
Rachel Dziekan
Grace Gleason
Zehui Gu
Beverly Hughes
Ashley Mello
Daeun Nam
Aditya Narayanan
Carlos Quintero
Helen SaTsu
University of Minnesota
Jonathan Aguirre
Zachary Baker
Eamon Cole
Katherine Oduguwa
Alex Welter
University of Nebraska Medical Center
Sunday Ogundepo
University of Nevada Reno, School of Medicine
Adnan Akif
University of North Carolina
Victor Adediwura
Yinglong Miao
Tyler Thompson
Kayli Winterfeldt
University of Puerto Rico
Keisy Rodriguez Villafañe
University of South Carolina
Christian Wohlfeld
University of Sydney
Sze Hon Kan
University of Texas Medical Branch
Lauren LeDay
Salvatore Meccia
University of Washington
Jennifer Liem
Jinyu Liu
Simar Singh
Vanderbilt University
Genevieve Hunn
Virginia Commonwealth University
Atharv Battu
Benjamin Tramonte
Wake Forest University
Sreekala Shenoy
Washington State University
Sung Hun Bae
Nikita Nirwan
Tyler Sacko
Sinem Ulusan
Authors
-


Janie McGlohon is a Biochemistry PhD
View all posts
candidate at the University of Buffalo.
She serves as the Junior Communications Officer for the ASPET Division of Drug Metabolism and Disposition. -


Simone Brixius-Anderko, PhD, is an Assistant Professor at the University of Pittsburgh School of Pharmacy. She currently serves as the Communications Officer for the ASPET Division for Drug Metabolism and Disposition.
View all posts

